A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization

Fertil Steril. 2004 Jun;81(6):1542-7. doi: 10.1016/j.fertnstert.2003.11.031.

Abstract

Objective: To determine the efficacy of natural-cycle IVF compared with controlled ovarian hyperstimulation in poor responders.

Design: Randomized, controlled study.

Setting: Private center for assisted reproduction.

Patient(s): One hundred twenty-nine women who were poor responders in a previous IVF cycle.

Intervention(s): Fifty-nine women underwent 114 attempts of natural-cycle IVF, and 70 women underwent 101 attempts of IVF with controlled ovarian hyperstimulation with microdose GnRH analog flare.

Main outcome measure(s): Number of oocytes retrieved, pregnancy rate (PR) per cycle, PR per transfer, and implantation rate.

Result(s): The poor responders treated with natural-cycle IVF and those treated with micro-GnRH analog flare showed similar PRs per cycle and per transfer. The women treated with natural-cycle IVF showed a statistically significant higher implantation rate (14.9%) compared with controls (5.5%). When subdivided into three groups according to age (<or=35 years, >or=36-39 years, >or=40 years), younger patients had a better PR than the other two groups.

Conclusion(s): In poor responders, natural-cycle IVF is at least as effective as controlled ovarian hyperstimulation, especially in younger patients, with a better implantation rate.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Buserelin / administration & dosage*
  • Dose-Response Relationship, Drug
  • Embryo Transfer
  • Female
  • Fertility Agents, Female / administration & dosage*
  • Fertilization in Vitro*
  • Gonadotropin-Releasing Hormone / analogs & derivatives*
  • Humans
  • Male
  • Maternal Age
  • Menstrual Cycle
  • Middle Aged
  • Ovulation Induction
  • Pregnancy
  • Pregnancy Rate
  • Retreatment
  • Sperm Injections, Intracytoplasmic

Substances

  • Fertility Agents, Female
  • Gonadotropin-Releasing Hormone
  • Buserelin